Trial Profile
Study of Pharmacokinetic Interaction Between TRUVADA and BILR 355 BS Plus Ritonavir
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 14 Jan 2020
Price :
$35
*
At a glance
- Drugs BILR 355 BS (Primary) ; Emtricitabine/tenofovir disoproxil fumarate; Ritonavir
- Indications HIV infections
- Focus Pharmacokinetics
- Sponsors Boehringer Ingelheim
- 15 Mar 2011 New trial record
- 01 Mar 2011 Results published in the Basic and Clinical Pharmacology and Toxicology.